Amdocs Reports Q4 2024 Financial Results

Ticker: DOX · Form: 6-K · Filed: Feb 5, 2025 · CIK: 1062579

Amdocs LTD 6-K Filing Summary
FieldDetail
CompanyAmdocs LTD (DOX)
Form Type6-K
Filed DateFeb 5, 2025
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: earnings, financial-results, sec-filing

TL;DR

Amdocs dropped its Q4 2024 earnings report on Feb 4th - check the 6-K for details.

AI Summary

Amdocs Limited announced its financial results for the quarter ended December 31, 2024, on February 4, 2025. The company filed a Form 6-K to report these results, including a press release and accompanying presentation as exhibits.

Why It Matters

This filing provides investors with the latest financial performance data for Amdocs, crucial for understanding the company's current health and future prospects.

Risk Assessment

Risk Level: low — This is a routine financial results filing and does not contain new material risks.

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

The purpose of this Form 6-K is to report the financial results of Amdocs Limited for the quarter ended December 31, 2024, as announced in a press release issued on February 4, 2025.

What exhibits are included with this filing?

This filing includes a press release announcing financial results (Exhibit 99.1) and an accompanying presentation (Exhibit 99.2).

What period do the financial results cover?

The financial results reported cover the quarter ended December 31, 2024.

When was the press release announcing these results issued?

The press release announcing these financial results was issued on February 4, 2025.

Does Amdocs file annual reports under Form 20-F or 40-F?

Amdocs Limited indicates that it files annual reports under cover of Form 20-F.

Filing Stats: 276 words · 1 min read · ~1 pages · Grade level 9.7 · Accepted 2025-02-04 19:58:07

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. AMDOCS LIMITED By: /s/ Matthew E. Smith Matthew E. Smith Secretary and Authorized Signatory Date: February 4, 2025

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing